^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

COX inhibitor

5d
Personalized pharmacotherapy of colorectal cancer (PubMed, Inn Med (Heidelb))
Colorectal cancer treatment is increasingly evolving into a precision oncology approach. Integration of molecular biomarkers enables tailored therapy decisions and opens new options, particularly in adjuvant and metastatic settings.
Review • Journal • MSi-H Biomarker • IO biomarker
|
HER-2 (Human epidermal growth factor receptor 2) • BRAF (B-raf proto-oncogene) • MSI (Microsatellite instability)
|
BRAF V600E • MSI-H/dMMR • BRAF V600
|
aspirin
6d
Ciclopirox reprograms effector responses and modulates Notch1 activation in activated human T cells. (PubMed, iScience)
The prodrug of CPX, fosciclopirox, was evaluated for safety and preliminary efficacy in patients with advanced solid tumors, including bladder cancer, and was found to inhibit cell proliferation, the γ-secretase complex, and Notch signaling. Mechanistically, CPX modulates Notch1 activation temporally and reprograms T cell metabolism by limiting glycolysis, both of which impact proliferative and effector responses in activated T cells. Together, these findings identify CPX as a modulator of T cell immunity, highlighting the broader immunologic implications for its therapeutic application.
Journal
|
NOTCH1 (Notch 1) • IFNG (Interferon, gamma) • IL2 (Interleukin 2)
|
fosciclopirox (CPX-POM)
6d
i-NEED: NEw migrainE Drugs Database (clinicaltrials.gov)
P=N/A, N=2641, Recruiting, IRCCS San Raffaele Roma | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Dec 2026
Trial completion date • Trial primary completion date
7d
Gastroprotective potential of canagliflozin in indomethacin-induced peptic ulcer: impact on inflammation, pyroptosis, autophagy, and gut integrity. (PubMed, Biochem Pharmacol)
Sixty rats were separated into 4 groups structured as: control group; ulcerated group; Cana group; Omeprazole group. Additionally, it restored intestinal permeability, which, in turn, aggravated peptic ulcer via endotoxemia. Hence, Cana is a promising gastroprotective agent against peptic ulcers through multiple cascades, evidenced by network pharmacology and experimental validation.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • SIRT1 (Sirtuin 1)
|
omeprazole
7d
A Study on Reducing Opioid Use After Ankle Arthroscopy (clinicaltrials.gov)
P=N/A, N=112, Completed, Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting --> Completed
Trial completion • Head-to-Head
8d
SMA-TB: Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis (clinicaltrials.gov)
P2, N=426, Terminated, Fundació Institut Germans Trias i Pujol | Recruiting --> Terminated; The impact of the COVID-19 pandemic on TB diagnosis affected greatly the recruitment rate and posed challenges to the trial's timeline, consuming the funding needed to continue the enrolment.
Trial termination
|
aspirin
9d
Fragment-based discovery of TopBP1 inhibitors integrated with AI-driven molecular docking. (PubMed, Magn Reson Lett)
Herein, we employ a fragment-based screening approach to identify four small-molecule ligands against the TopBP1 BRCT7-8 domain: adamantane acetic acid (ADA), zaltoprofen, diclofenac sodium, and quinine...Our NMR screening nominates orthosteric inhibitors, as well as quinine, a potential allosteric inhibitor. It shall also facilitate following structure-based design of more potent allosteric and orthosteric inhibitors of TopBP1.
Journal
|
BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1) • BACH1 (BTB Domain And CNC Homolog 1)
9d
PROMISE: Pro-urokinase for Extended-Window Posterior Circulation Stroke (clinicaltrials.gov)
P3, N=586, Not yet recruiting, The First Affiliated Hospital of Zhengzhou University
New P3 trial
|
aspirin
11d
New trial
|
aspirin
12d
Low Dose Aspirin Alerts in High-Risk Pregnancies (clinicaltrials.gov)
P=N/A, N=830, Completed, Geisinger Clinic | Active, not recruiting --> Completed
Trial completion
|
aspirin
13d
Cancer Surveillance in Lynch Syndrome: A Scoping Review of International and National Guidelines. (PubMed, Genet Med)
Aspirin chemoprevention was widely supported despite dose variability. These findings highlight opportunities for harmonization, gene-stratified precision prevention, and higher-quality prospective evidence to guide care.
Review • Journal
|
MLH1 (MutL homolog 1) • MSH2 (MutS Homolog 2)
|
aspirin